MRI-based study to classify and grade kidney tumors
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study uses MRI scans to help doctors better identify the type and severity of kidney tumors. It may lead to more accurate diagnoses without needing extra tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a kidney tumor.
- You have had an MRI scan of your kidney before surgery.
- You have a pathology report that states the tumor type and grade.
- Your MRI images are available and clear enough to be analyzed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/MR scanner to take detailed pictures of kidney masses. The goal is to improve diagnosis and help decide the best treatment, without needing a biopsy or prior treatment.
This study uses a computer program (deep learning) to look at your kidney CT scan and tell if your cancer is more advanced (stage T3) or earlier (stage T1-T2). The goal is to help doctors plan the best treatment for you.
This trial uses artificial intelligence (AI) to analyze standard, non-contrast CT scans to identify and understand kidney tumors. It aims to help doctors make better decisions without needing special dye injections.
This study tests whether MRI scans can help doctors make better decisions about treatment for small kidney tumors. If you have a kidney mass up to 4 cm and are planning surgery, you may be able to join.
This study uses artificial intelligence to help plan the best surgery for kidney tumors. You may be eligible if you have a kidney tumor that can be removed with surgery and have had a special CT scan within the past month.
This study uses a special MRI scan to look at the kidneys in people with different kinds of kidney disease, including acute kidney injury, chronic kidney disease, vasculitis, and after a kidney transplant. The goal is to better understand these conditions.
Hear when a new Renal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.